Diagnosing Alopecias: Key Elements and Insights from Clinical Cases
Hair loss is a common yet complex condition that presents a significant challenge for both patients and dermatologists alike. Accurate diagnosis and effective management often require a meticulous and nuanced approach that enables the physician to discern subtle clues that distinguish between various etiologic forms of alopecia. At the 2025 Orlando Dermatology, Aesthetic, and Surgical Conference, …
Hair loss is a common yet complex condition that presents a significant challenge for both patients and dermatologists alike. Accurate diagnosis and effective management often require a meticulous and nuanced approach that enables the physician to discern subtle clues that distinguish between various etiologic forms of alopecia. At the 2025 Orlando Dermatology, Aesthetic, and Surgical Conference, … Continue reading "Diagnosing Alopecias: Key Elements and Insights from Clinical Cases"
[vc_row][vc_column][vc_column_text css=""]Despite decades of educational efforts, there is growing public skepticism over sunscreen’s safety and efficacy. Researchers from Chicago sought to synthesize the current scientific understanding of sunscreen in order to help dermatology clinicians address concerns. The findings are published in the February Journal of Drugs in Dermatology.
I intervie … 
Working with industry is a common career goal of dermatologists, whether it’s by serving on an advisory board, obtaining a grant, or collaborating in another way. So how does a dermatologist land these industry opportunities? Watch as Dr. Adam Friedman, co-chair of the ODAC Dermatology Conference, outlines how to build bridges with industry partners. Find out why it’s important to understand t … 
At the 2025 ODAC Dermatology Conference, renowned dermatologist and conference co-chair Adam Friedman, MD, delivered an insightful lecture, How I Treat Rosacea in 2025. He explored the latest advancements in managing one of dermatology’s most prevalent conditions, highlighting key triggers, associated comorbidities, and evolving treatment strategies. With global rosacea prevalence reported as hi … 
At the forefront of the evolving treatment landscape for cutaneous squamous cell carcinoma (cSCC), Dr. David M. Miller—a board-certified internist, dermatologist, and medical oncologist at Massachusetts General Hospital—delivered a highly informative lecture on the past, present, and future of immunotherapy for cSCC at ODAC 2025. With his unique expertise across three disciplines, Dr. Miller e … 